Thymoma Clinical Trial - Single Cell Sequencing Analysis of Thymoma

Status Recruiting

Clinical Trial Summary

The purpose of this study is to understand how genetics play a role in thymoma. Intratumoral heterogeneity is among the greatest challenges in precision cancer therapy. However, developments in high-throughput single-cell RNA sequencing (scRNA-seq) may now provide the statistical power to dissect the diverse cellular populations of tumors. This study aims to find out how it affects genetic and protein expression in patients with malignant thymoma, compared to Benign thymoma, at a single-cell level using a flow cytometry and RNA-sequencing protocol.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04162691
Study type	Observational
Source	Zhejiang Cancer Hospital
Contact	An ZHAO, MD, PHD
Phone	8688122413
Email	zhaoan@zjcc.org.cn
Status	Recruiting
Phase
Start date	June 6, 2020
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Terminated	`NCT00818090` - Paclitaxel and Cisplatin for Thymic Neoplasm	Phase 2
Completed	`NCT00332969` - Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma	Phase 2
Completed	`NCT00921739` - Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies	Phase 1
Recruiting	`NCT05255965` - IL-8+ naïve T Cells as a Biomarker for Thymoma Identification
Withdrawn	`NCT02948855` - Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
Completed	`NCT00387868` - Preoperative Treatment of Patients With High Risk Thymoma	Phase 2
Completed	`NCT01272817` - Nonmyeloablative Allogeneic Transplant	N/A
Recruiting	`NCT03466827` - Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma	Phase 2
Completed	`NCT02220855` - A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas	Phase 2
Completed	`NCT03288662` - Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors	N/A
Active, not recruiting	`NCT01242072` - Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies	Phase 1
Recruiting	`NCT06029621` - Robot-assisted vs VATS for Thymoma	N/A
Active, not recruiting	`NCT03921671` - Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)	Phase 2
Active, not recruiting	`NCT01621568` - Sunitinib for Advanced Thymus Cancer Following Earlier Treatment	Phase 2
Recruiting	`NCT05262582` - Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy	N/A
Terminated	`NCT01100944` - A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies	Phase 1/Phase 2
Active, not recruiting	`NCT03968315` - An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma	N/A
Recruiting	`NCT06086327` - Application of 68Ga-Pentixafor PET/CT for Thymoma	Early Phase 1
Completed	`NCT01364727` - A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies	Phase 2